Final answer:
Repaglinide (Prandin) belongs to the meglitinides option (C) class of oral antihyperglycemic drugs.
Step-by-step explanation:
Repaglinide (Prandin) belongs to the Meglitinides option (C) class of oral antihyperglycemic drugs. Meglitinides work by stimulating the beta cells of the pancreas to secrete insulin. They have a shorter duration of action compared to other antihyperglycemic drugs.
In the case given, Javier is taking repaglinide along with other medications to manage his type 2 diabetes. However, his poor glycemic control, as evidenced by his elevated A1C and finger stick test result, indicates that his current treatment plan may not be effective. It is important for him to see his doctor and make adjustments to his medications and lifestyle to better manage his diabetes.